Scrip
Market Insight - Microdosing reaching a tipping point?
05 February 2010
Phil Greenfield
Please Login to read the full article.
05 February 2010
Phil Greenfield
Advocates of microdosing, a technique that involves testing very small doses of products in humans, think it will improve the efficiency of drug development by flagging at an early stage those product candidates that are likely to fail. So why has it yet to enter the mainstream, asks...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Swifter market access for drugs will require a revolution
- FDA advisory committee recommends approval of miglustat in Niemann-Pick disease
- EU consults on submission of result-related clinical trial data to EudraCT
- Teratomas a concern for stem cell-based therapies, EMA meeting hears
ANALYSIS
- Executive Briefing - Getting to grips with advanced therapies in the EU
- Executive Briefing – Brazil emerges as a saviour for pharma
COMMENT
Other Informa Comment
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
